Looking to publish in Clinical & Translational Immunology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowClinical & Translational Immunology is an open access, fully peer-reviewed journal devoted to publishing cutting-edge advances in biomedical research for scientists and physicians. It covers cancer biology, cardiovascular research, gene therapy, immunology, vaccine development, and disease pathogenesis and therapy at the earliest phases of investigation.
Looking to publish in Clinical & Translational Immunology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Clinical & Translational Immunology accepts the following article types. Click on an article type to view submission instructions.
Original Articles
Review Articles
Short Communications
Case Reports
Recent Publications
Myeloid HDAC7 drives liver inflammation and systemic glucose dysregulation during diet‐induced obesity
Yizhuo Wang, Divya Ramnath, Kaustav Das Gupta, P Prakrithi, Kavita Bisht, Gregory C Miller, Zherui Xiong, Yujun Wan, Ellen N Tejo, James EB Curson, Rishika Abrol, Sahar Keshvari, Kimberley S Gunther, Jordan D Atkinson, Zhixuan Loh, Jessica A Engel, Christian R Engwerda, Sabrina Sofia Burgener, Kate Schroder, David P Fairlie, Andrew D Clouston, Elizabeth E Powell, Katharine M Irvine, Mitchell A Sullivan, Jean‐Pierre Lévesque, Quan Nguyen, Matthew J Sweet, Denuja Karunakaran
Alterations of circulating innate lymphoid cells in recent‐onset type 1 diabetes
Ariadna Roig, David Perna‐Barrull, Eva Aguilera, Sebastián Pérez, Marta Vives‐Pi, Raquel Planas
Control of poorly immunogenic tumors with systemic STING agonist‐loaded liposomes targeting cross‐presenting dendritic cells
Bijun Zeng, Meghna Talekar, Thais Aragao‐Horoiwa, Amy Cameron, Guangzu Zhao, Yulia Zybina, Wendy Blumenschein, Karyn van de Mark, Wittaya Suwakulsiri, Gretchen A Baltus, Riccardo Dolcetti, Ranjeny Thomas
Single‐cell and repertoire profiling reveals immune remodelling in paediatric upper airway: insights from adenoid hypertrophy
Chao Wang, Yufei Pan, Xiao Han, Kai Sun, Jing Li, Yuanyuan Lu, Zhenkun Yu
Enhanced Fc and complement activity of Fc‐modified avelumab boosts anti‐tumor activity but promotes NK cell fratricide
Lachlan J Dobson, Barry D Hock, Ariana HT Drabble, Liping Goddard, Judith L McKenzie, Sean A MacPherson, Alexander D McLellan
Frequently asked questions
How long does it take to publish?
Submission to first decision: median 5 days. Submission to acceptance: median 146 days. Acceptance to publication: median 22 days.
Reformat to Clinical & Translational Immunology using Livewrite PremiumIs a cover letter required?
A cover letter is not specifically required; a proposal is requested for Review articles before submission.
Reformat to Clinical & Translational Immunology using Livewrite PremiumWhat are the publication costs?
Accepted and published articles are fully open access and subject to an APC of $3,380 USD / £2,580 GBP / €3,070 EUR, with member discounts and select article-type discounts available; no submission fees or page charges.
Reformat to Clinical & Translational Immunology using Livewrite Premium